Mainstream

Biogen, Eisai begin rolling FDA submissions for Leqembi injectable for starting dose

Biogen, Eisai begin rolling FDA submissions for Leqembi injectable for starting dose

Post Contentbiib, esalf, esaiyRead More

You might also be interested in reading BitGo posts $19M Q2 loss despite 80% revenue surge to $4.3B.

September 3, 2025
In Mainstream